|
 |
|
First and Largest Stem Cell Banking and Regenerative Medicine Company in Malaysia
 |
StemLife is the first stem cell banking and therapeutics company in Malaysia. Established in 2001 with blessings from the Malaysian Government, StemLife was awarded the prestigious MSC status in 2002, BioNexus Status in 2007 and on 17 October 2006 the company went for listing on the MESDAQ. As of 2008, StemLife is a fully licensed cord blood banking facility under the Private Healthcare Services & Facilities Act (PHFS Act), 1998, under the Ministry of Health Malaysia.
|
| StemLife is proud to be the first cord blood banking company in Malaysia to provide umbilical cord blood-derived stem cells for bone marrow transplantation in paediatric leukemia and adult stem cells for use in treatment of blood-related disorders, heart disease, foot ulcers and sports and trauma injuries. A founding member of the Asia Pacific Cord Blood Bank Consortium, an active participant in R&D projects, and with close collaborations with over 150 leading hospitals and over 450 renown specialists, StemLife is ranked as one of the largest and most reputable stem cell companies in South East Asia.
|
| |
STEMLIFE STEM CELL BANKING & THERAPEUTIC SERVICES |
|
|
| StemLife offers stem cell banking services for immediate or future use to expecting parents who wish to store their baby’s umbilical cord blood, and to individuals who wish to store their own adult stem cells. In addition, StemLife provides stem cell consultancy and therapeutic services, working closely with medical specialists to provide cost-efficient and personalized treatment. Current stem cell therapies available at StemLife are applications in oncology, haematology, heart disease and diabetic foot ulcers. StemLife also welcomes specific enquiries for other conditions. |
|
| |
COMPREHENSIVE LABORATORY WITH CRYOGENIC STORAGE AND TESTING FACILITIES |
|
|
StemLife operates its own 24-hour processing, testing, and cryopreservation facility in central KL. In accordance with international standards of stem cell banking, StemLife uses FDA-approved multi-compartmentalized stem cell storage systems for safe and secure long-term cryogenic storage. StemLife participates in stringent international external quality assurance and accreditation programs organized by the College of American Pathologists (CAP, USA). Equipped with cleanroom processing, its own pathogenic testing facilities and advanced secure storage areas, StemLife is the most comprehensive stem cell company in the country.
| |
LED BY CREDIBLE & PROFESSIONAL MANAGEMENT TEAM |
|
|
StemLife is helmed by a team of trained and experienced individuals who are very committed to the medical care of patients. Sharon Low, its managing director, is a laboratory-trained biochemist from Bristol University, UK. Prof. Dr. TC Aw, previously head of laboratory medicine at National University Hospital, Singapore, is chief medical officer and co-founder of StemLife with experience in stem cell banking for conditions in oncology and haematology. Additionally, StemLife has an advisory panel of medical doctors on its team with a collective experience of more than 30 years each.
| |
REPUTABLE INTERNATIONAL & LOCAL MEDICAL EXPERT ADVISORS |
|
|
StemLife’s panel of advisors hail from a wide range of medical expertise. Comprising of doctors and scientists from five continents with expertise in haematology, obstetrics and gynaecology, oncology, pharmacology and pathology, these international advisors serve to guide and update StemLife on the latest stem cell therapeutic applications. Local advisory panel members include specialists in stem cell transplantation, haematology, sports medicine, oncology and ENT surgery and also keep StemLife on the forefront of stem cell technological advancements and news.
| |
PROVEN & ESTABLISHED CLINICAL CARE |
|
|
StemLife has successfully released more stem cell units for therapy than any other stem cell bank in South East Asia. This impressive track record is proof of StemLife’s expertise and a testament to the trust by doctors and patients both locally and internationally as the stem cell bank of choice.
^ Back to Top |
|
|
| |
|
